Advances in the research of exosomes in renal cell carcinoma: from mechanisms to applications

Renal cell carcinoma (RCC) is one of the most malignant urological tumors. Currently, there is a lack of molecular markers for early diagnosis of RCC. The 5-year survival rate for early-stage RCC is generally favorable; however, the prognosis takes a significant downturn when the tumor progresses to...

Descripción completa

Detalles Bibliográficos
Autores principales: Rui, Rui, Zhou, Liqun, He, Shiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628008/
https://www.ncbi.nlm.nih.gov/pubmed/37942325
http://dx.doi.org/10.3389/fimmu.2023.1271669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628008/
https://www.ncbi.nlm.nih.gov/pubmed/37942325
http://dx.doi.org/10.3389/fimmu.2023.1271669

Ejemplares similares